Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group

por Guirado, M., Sanchez-Hernandez, A., Pijuan, L., Teixido, C., Gómez-Caamaño, A., Cilleruelo-Ramos, Á.
Publicado 2021

Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study

por Angulo, J. C., Ciria Santos, J. P., Gómez-Caamaño, A., Poza de Celis, R., González Sala, J. L., García Garzón, J. M., Galán-Llopis, J. A., Pérez Sampietro, M., Perrot, V., Planas Morin, J.
Publicado 2022

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastase...

por de la Piedra, C, Alcaraz, A, Bellmunt, J, Meseguer, C, Gómez-Caamano, A, Ribal, M J, Vázquez, F, Anido, U, Samper, P, Esteban, E, Álvarez-Ossorio, J L, Lara, P C, San José, L A, Contreras, J A, del Alba, A G, González-Gragera, B, Tabernero, A J, González-Enguita, C, Fernández, J M, García-Escudero, A, Gómez-Veiga, F, Méndez, M J, Segarra, J, Virizuela, J A, Carles, J, Lassa, A, Calderero, V, Constela, M, Delgado, D, Mañas, A, Murias, A, Reynes, G, Rodriguez, B, Rubio, G, Sánchez, E, Unda, M, Solsona, E, Martínez-Javaloyas, J M, Comet-Batlle, J, Quicios, C, Martín-Fernández, M, Mahillo-Fernández, I, Morote, J
Publicado 2013